Creades AB (STO:CRED.A)

Theseus Pharmaceuticals Statistics

Total Valuation

Creades AB has a market cap or net worth of SEK 10.60 billion. The enterprise value is 9.89 billion.

Market Cap	10.60B
Enterprise Value	9.89B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	Oct 28, 2025

Share Statistics

Creades AB has 135.76 million shares outstanding.

Current Share Class	93.10M
Shares Outstanding	135.76M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.73%
Owned by Institutions (%)	14.97%
Float	54.63M

Valuation Ratios

The trailing PE ratio is 8.48.

PE Ratio	8.48
Forward PE	n/a
PS Ratio	7.80
PB Ratio	0.99
P/TBV Ratio	0.99
P/FCF Ratio	n/a
P/OCF Ratio	82.19
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	7.91
EV / Sales	7.27
EV / EBITDA	7.98
EV / EBIT	8.00
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.23, with a Debt / Equity ratio of 0.00.

Current Ratio	3.23
Quick Ratio	3.21
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	n/a
Interest Coverage	1,237.00

Financial Efficiency

Return on equity (ROE) is 12.25% and return on invested capital (ROIC) is 7.57%.

Return on Equity (ROE)	12.25%
Return on Assets (ROA)	7.41%
Return on Invested Capital (ROIC)	7.57%
Return on Capital Employed (ROCE)	11.53%
Revenue Per Employee	151.11M
Profits Per Employee	138.89M
Employee Count	9
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.77% in the last 52 weeks. The beta is 1.18, so Creades AB's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	+9.77%
50-Day Moving Average	77.60
200-Day Moving Average	75.78
Relative Strength Index (RSI)	50.45
Average Volume (20 Days)	83,431

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Creades AB had revenue of SEK 1.36 billion and earned 1.25 billion in profits. Earnings per share was 9.21.

Revenue	1.36B
Gross Profit	1.36B
Operating Income	1.24B
Pretax Income	1.25B
Net Income	1.25B
EBITDA	1.24B
EBIT	1.24B
Earnings Per Share (EPS)	9.21

Balance Sheet

The company has 720.00 million in cash and 9.00 million in debt, giving a net cash position of 711.00 million or 5.24 per share.

Cash & Cash Equivalents	720.00M
Total Debt	9.00M
Net Cash	711.00M
Net Cash Per Share	5.24
Equity (Book Value)	10.72B
Book Value Per Share	78.98
Working Capital	499.00M

Cash Flow

Operating Cash Flow	129.00M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 90.96% and 91.91%.

Gross Margin	100.00%
Operating Margin	90.96%
Pretax Margin	91.91%
Profit Margin	91.91%
EBITDA Margin	90.96%
EBIT Margin	90.96%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 2.05%.

Dividend Per Share	1.60
Dividend Yield	2.05%
Dividend Growth (YoY)	3.23%
Years of Dividend Growth	1
Payout Ratio	17.36%
Buyback Yield	n/a
Shareholder Yield	2.06%
Earnings Yield	11.79%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on April 27, 2021. It was a forward split with a ratio of 10.

Last Split Date	Apr 27, 2021
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	5